Categories
· Health/Science
· Ethnic Issues
· COPD
USA, by State
· Michigan
|
Two multi-center trials will study the genetic roots of lung disease in smokers and the effects of oxygen therapy
Jump to full article: University of Michigan Health System, 2009-11-18
Intro: Why do some smokers develop lung disease and others don't? And just how effective is supplemental oxygen therapy in treating patients with emphysema?
The University of Michigan Health System will try to find out, through two new multi-center research studies that seek to improve diagnosis and treatment for millions of people affected by emphysema, chronic bronchitis and other lung diseases. Together, those conditions are known as chronic obstructive pulmonary disease (COPD). Both studies are now accepting new participants.
While smoking is the leading cause of COPD, only 25 percent of smokers develop the disease. For the COPDGeneTM study, U-M will enroll hundreds of current or former smokers - with and without COPD - between 45 and 80 years of age to discover the inherited factors that make some people more likely to develop COPD. U-M is one of 21 leading medical centers participating in the study, which will enroll more than 12,000 people across the United States.
COPDGeneTM is one of the first COPD studies to include a large percentage of African American participants.
Jump to full article » |